510(k) Report

510(k) · Cleared

Cleared

2.9F Cragg-Mcnamara Valved Infusion Catheter

K964868510(k) TraditionalCleared May 20, 1997167-day reviewClass II21 CFR 870.1210

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Micro Therapeutics, Inc. · KRA Catheter, Continuous Flush

Cleared on May 20, 1997 as substantially equivalent to K940634 (Micro Therapeutics, Inc., 1994) after a 167-day review. Its family tree reaches back 1 generation to 1994. 41 later devices descend from it.

Decided
May 20, 1997
Review
167 days
Class
Class II
Product code
KRA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K940634 (1994). 41 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2013: 1 descendant cleared2004: 3 descendants cleared2005: 3 descendants cleared2006: 4 descendants cleared2007: 3 descendants cleared2016: 2 descendants cleared2008: 3 descendants cleared2025: 1 descendant cleared2018: 2 descendants cleared2026: 4 descendants cleared2011: 1 descendant cleared2019: 4 descendants cleared2022: 2 descendants cleared2021: 2 descendants cleared2024: 4 descendants cleared2020: 2 descendants clearedK940634 · Micro Therapeutics Infusion Catheter · Micro Therapeutics, Inc. · 19941990200020102020
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 2 descendants3 generations forward: 2 descendants4 generations forward: 1 descendant5 generations forward: 2 descendants6 generations forward: 5 descendants7 generations forward: 5 descendants8 generations forward: 4 descendants9 generations forward: 4 descendants10 generations forward: 5 descendants11 generations forward: 6 descendants12 generations forward: 2 descendants13 generations forward: 1 descendant K940634 · Micro Therapeutics Infusion Catheter · Micro Therapeutics, Inc. · 19940+5+10
  1. Root · 1 generation backK940634 Micro Therapeutics Infusion CatheterMicro Therapeutics, Inc. · 1994
  2. This deviceK964868 2.9F Cragg-Mcnamara Valved Infusion CatheterMicro Therapeutics, Inc. · 1997
  3. Descendant · cites it directly · 39 of its ownK041629 Lysus Infusion SystemEkos Corp. · 2004
  4. Descendant · 2 generations on · 38 of its ownK042456 Lysus Infusion SystemEkos Corp. · 2004 · Recalled
  5. Descendant · 3 generations on · 35 of its ownK051319 Lysus Infusion SystemEkos Corp. · 2005
  6. Descendant · 4 generations on · 34 of its ownK052071 Lysus Infusion SystemEkos Corp. · 2005
  7. Descendant · 5 generations on · 27 of its ownK060422 Lysus Infusion SystemEkos Corp. · 2006 · Recalled

Showing 5 of 41 descendants. See all descendants

Descendants cleared per year

2004: 32005: 32006: 42007: 32008: 32011: 12013: 12016: 22018: 22019: 42020: 22021: 22022: 22024: 42025: 12026: 4
2004high 4 (2006) · low 0 (2009)2026

Most influential descendants

Showing 5 of 41 · See all
  • K041629Lysus Infusion SystemEkos Corp. · 2004 · cites it directly39descendants
  • K042456Lysus Infusion SystemEkos Corp. · 2004 · 2 generations on38descendants
  • K051319Lysus Infusion SystemEkos Corp. · 2005 · 3 generations on35descendants
  • K052071Lysus Infusion SystemEkos Corp. · 2005 · 4 generations on34descendants
  • K060422Lysus Infusion SystemEkos Corp. · 2006 · 5 generations on27descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K940634Micro Therapeutics Infusion CatheterMicro Therapeutics, Inc.1994—
0 (this device)K9648682.9F Cragg-Mcnamara Valved Infusion CatheterMicro Therapeutics, Inc.1997—
+1K041629Lysus Infusion SystemEkos Corp.2004—
+2K042456Lysus Infusion SystemEkos Corp.20043
+3K051319Lysus Infusion SystemEkos Corp.2005—
+4K052071Lysus Infusion SystemEkos Corp.2005—
+5K060422Lysus Infusion SystemEkos Corp.20061

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200430
200530
200640
200730
200830
201110
201310
201620
201820
201940
202020
202120
202220
202440
202510
202640
FIG. 1 — Lineage of K964868, 1994–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KRA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KRA device

  1. #1 K253509 TriSalus TriNav Advance Infusion Systemscore 14.4 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K940634Micro Therapeutics Infusion Catheter
Summary page 1
…utics, Inc. 1062-F Calle Negocio San Clemente, CA 92673 Contact Linda D'Abate Clinical and Regulatory Affairs Predicate Devices Micro Therapeutics Infusion Catheters (K940634, October 14, 1994) Device Description The 2.9F Cragg-McNamara™ Valved Infusion Catheter is a single lumen plastic catheter suit…
Micro Therapeutics, Inc.1994—

What descends from it? (41)

See all 41

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K041629Lysus Infusion SystemEkos Corp.200439
K123235Equaflow Multivalve Infusion CatheterCook Incorporated20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K041629 (Ekos Corp., 2004) has gone furthest, with 39 descendants of its own.

How does its category compare?

All KRA devices

KRA Catheter, Continuous Flush: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KRA

1in 2025

2007: 52008: 72009: 52010: 22011: 22012: 32013: 32014: 42016: 82017: 42018: 42019: 42020: 62021: 62022: 62023: 72025: 12026 (partial year): 5
2007high 8 (2016) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRA

63in 2023

2007: 44 days median2008: 144 days median2009: 69 days median2012: 29 days median2013: 126 days median2014: 61 days median2016: 122 days median2017: 166 days median2018: 178 days median2019: 133 days median2020: 29 days median2021: 108 days median2022: 228 days median2023: 63 days median2026 (partial year): 268 days median
2007high 268 (2026) · low 29 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KRA

41so far in 2026, the most since 2007

2007: 22008: 62009: 82010: 262011: 32012: 32013: 22014: 3, 2 Class I2015: 12016: 3, 1 Class I2019: 4, 4 Class I2020: 12023: 22026 (partial year): 41
2007high 41 (2026) · low 0 (2017)2026

Class I (7 since 2007) Class II/III not classified

Adverse event reports per year · KRA

980in 2025

2007: 1182008: 1172009: 1872010: 3552011: 2392012: 2172013: 2092014: 2762015: 3392016: 4182017: 5382018: 4342019: 4182020: 3812021: 4402022: 5432023: 8292024: 9422025: 980
2007high 980 (2025) · low 117 (2008)2025

MAUDE reports naming product code KRA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20075442118
200871446117
20095698187
20102—26355
20112—3239
20123293217
201331262209
20144613 (2)276
20150—1339
201681223 (1)418
201741660538
201841780434
201941334 (4)418
20206291381
202161080440
202262280543
20237632829
20240—0942
20251—0980
2026526841—

What is it indicated for?

The 2.9F Cragg-McNamara™ Valved Infusion Catheter is intended to be used for the controlled selective infusion of physician specified pharmacological agents and radiopaque contrast media into the general vasculature. It is not intended for coronary, neurological, pediatric or neonatal use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K964868: 2.9F Cragg-Mcnamara Valved Infusion Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K964868

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026